Sebastian Kobold

10.6k citations
145 papers · 5.8k · 5 hit papers · h-index 36

Impact in

  • Oncology top 0.5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers
  • Immunology top 0.5%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Immune cells in cancer

Papers in

    • CAR-T cell therapy research 79
    • Cancer Immunotherapy and Biomarkers 16
    • Immunotherapy and Immune Responses 32
    • Immune Cell Function and Interaction 32

Sebastian Kobold

135 papers receiving 5.7k citations

Sebastian Kobold's Hit Papers

Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming 2023 · 159 citations
1590+2+5Years since publication100200300400500

Peers

Sebastian Kobold
Comparison fields: 5 of 127
  • Oncology 3.1k
  • Immunology 2.5k
  • Hematology 258
  • Cancer Research 327
  • Molecular Biology 1.6k
Replace Marco Donia with:
Marco Donia Denmark
Benjamin G. Vincent United States
Pedro Berraondo Spain
Jitka Fučíková Czechia
Philipp Beckhove Germany
Michel Obéid Switzerland
Sumit K. Subudhi United States
Aitziber Buqué United States
Andrea Schietinger United States
Antoine Tesnière France
Sebastian Kobold relative to Marco Donia Denmark Marco Donia's profile →
Citations per field
00.5×1.5×
Marco Donia · 1×
Citations per year

Countries citing papers authored by Sebastian Kobold

Since Specialization
Citations

This map shows the geographic impact of Sebastian Kobold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sebastian Kobold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sebastian Kobold more than expected).

Fields of papers citing papers by Sebastian Kobold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sebastian Kobold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sebastian Kobold. The network helps show where Sebastian Kobold may publish in the future.

Co-authors

The 25 scholars most cited alongside Sebastian Kobold, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Sebastian Kobold Line = papers co-authored together Sebastian Kobold links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Interleukins in cancer: from biology to therapy
Hit paper breakdown →
2021564
2
Advances in cancer immunotherapy 2019 – latest trends
Hit paper breakdown →
2019407
3
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Hit paper breakdown →
2019393
4 2018345
5
Teaching an old dog new tricks: next-generation CAR T cells
Hit paper breakdown →
2018340
6
Mitochondrial dysfunction promotes the transition of precursor to terminally exhausted T cells through HIF-1α-mediated glycolytic reprogramming
Hit paper breakdown →
2023159
7 2014144
8 2019142
9 2020128
10 2019127
11 2014120
12 2022118
13 2021116
14 2019108
15 2017106
16 201593
17 201881
18 200980
19 201880
20 200974

About Sebastian Kobold

Sebastian Kobold is a scholar working on Oncology, Immunology, Molecular Biology, Biomedical Engineering and Radiology, Nuclear Medicine and Imaging, having authored 145 papers that have together received 5.8k indexed citations. Recurring topics across this work include CAR-T cell therapy research (79 papers), Immunotherapy and Immune Responses (32 papers), Immune Cell Function and Interaction (32 papers), Cancer Immunotherapy and Biomarkers (16 papers), Monoclonal and Polyclonal Antibodies Research (15 papers), Nanowire Synthesis and Applications (14 papers), Viral Infectious Diseases and Gene Expression in Insects (10 papers) and Virus-based gene therapy research (8 papers). The work is most often cited by research in Oncology (3.1k citations), Immunology (2.5k citations), Hematology (258 citations), Cancer Research (327 citations) and Molecular Biology (1.6k citations). Sebastian Kobold has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Stefan Endres, Peter Libby, Bruno L. Cadilha, Michael von Bergwelt‐Baildon, Mohamed-Reda Benmebarek, Stefanie Lesch, Charles A. Dinarello, Daria Briukhovetska, Janina Dörr and Nicholas Tokarew. Their work appears in journals such as Blood, Frontiers in Immunology, Cancer Immunology Immunotherapy, Journal for ImmunoTherapy of Cancer and Oncotarget.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact